Becton, Dickinson and Company's stock performance experienced an increase as
Foyston Gordon & Payne Inc raised its stock position. However, shareholders registered a
15% loss over the past year. The company remains a key
Growth Stock and
Value Stock for long-term investments. Michael Feld was recently appointed as President of the
Life Sciences Segment. A sizable decline in short interest was observed for the company. IA Global Asset Management Inc decided to boost its holdings in the company. It appears that the company's stock might emerge as a strong buy, following its predicted performance as a
Top Dividend Aristocrat of 2024. They exceeded Q2 earnings estimates, raising their fiscal 2024 guidance. The company has also acquired
Edwards Lifesciences' Critical Care Product Group for $4.2B cash. It declared dividends, but also saw a decline based on lower than expected 2024 Guidance. Becton, Dickinson is set to expand its smart connected care solutions, following the historical acquisition. AMI Asset Management and Fifth Third Bancorp have sold shares of Becton, Dickinson. Consequently, there has been a demonstration of robust financial performance, amidst global challenges.
Becton Dickinson and BDX News Analytics from Thu, 09 Nov 2023 08:00:00 GMT to Sun, 01 Sep 2024 13:19:00 GMT -
Rating 7
- Innovation 5
- Information 9
- Rumor -4
